Reports

The global Morphine Sulphate market was valued at 3013 million in 2025 and is projected to reach US$ 3868 million by 2032, at a CAGR of 3.7% during the forecast period.

The global Morphine Hydrochloride market was valued at 1826 million in 2025 and is projected to reach US$ 2312 million by 2032, at a CAGR of 3.5% during the forecast period.

The global Medical Morphine market was valued at 4091 million in 2025 and is projected to reach US$ 5181 million by 2032, at a CAGR of 3.5% during the forecast period.

The global Bacillus Licheniformis market was valued at 59.36 million in 2025 and is projected to reach US$ 89.07 million by 2032, at a CAGR of 6.1% during the forecast period.

The global Human Coagulation Factor Ⅷ market was valued at 7420 million in 2025 and is projected to reach US$ 9858 million by 2032, at a CAGR of 4.1% during the forecast period.

The global Antihypertensive Agents market was valued at 23651 million in 2025 and is projected to reach US$ 31723 million by 2032, at a CAGR of 4.3% during the forecast period.

The global Glucosamine Chondroitin Calcium Tablets market was valued at 1176 million in 2025 and is projected to reach US$ 1915 million by 2032, at a CAGR of 7.0% during the forecast period.

The global Morphine Sulfate market was valued at 3013 million in 2025 and is projected to reach US$ 3868 million by 2032, at a CAGR of 3.7% during the forecast period.

The global Quinine Sulfate market was valued at 384 million in 2025 and is projected to reach US$ 487 million by 2032, at a CAGR of 3.5% during the forecast period.

The global Acellular Pertussis-based Hexavalent Combination Vaccine market was valued at 2147 million in 2025 and is projected to reach US$ 3231 million by 2032, at a CAGR of 6.2% during the forecast period.